https://pubmed.ncbi.nlm.nih.gov/39576960/
Lasalocid A selectively induces the degradation of MYD88 in lymphomas harboring the MYD88 L265P...
Myeloid differentiation primary response protein 88 (MYD88) is a key adaptor molecule in the signaling pathways of toll-like receptor and interleukin-1...
https://publikationen.uni-tuebingen.de/xmlui/handle/10900/65365
MYD88 L265P and CXCR4 mutations in lymphoplasmacytic lymphoma identify cases with high disease...